Renishaw is pleased to announce that a neuromate® stereotactic robotic system has been installed at the the Department of Stereotaxy and Functional Neurosurgery of the University Hospital in Cologne, Germany.
Renishaw is pleased to announce that the Saudi Food and Drug Authority has cleared the neuromate® stereotactic neurosurgical robotic system. A neuromate system has recently been installed and the first surgical procedures have been performed at the King Fahad Medical City Hospital in Riyadh. This is the first placement of a neurosurgical robot in the Kingdom of Saudi Arabia.
Renishaw is pleased to announce that the Neurosurgery Department of Centre Hospitalier Universitaire Pasteur in Nice, France have now completed their first neurosurgical robotic procedures using Renishaw’s neuro|mate® stereotactic system.
Renishaw is pleased to announce that the first neurosurgical robotic procedure with its NeuroMate® stereotactic system has taken place at the Neurosurgery Department of Hospital Nacional Guillermo Almenara in Lima, Peru.
Cutting-edge robot technology that enables neurosurgeons to deliver sophisticated neuro-implantable devices with pinpoint accuracy will soon be in place at the UK’s North Bristol NHS Trust. The Friends of Frenchay Hospital have agreed to provide the £270,000 funding for the neuromate® robot made by Renishaw plc.
Renishaw, a world leader in engineering technologies, introduced an exciting range of high precision systems for functional and stereotactic neurosurgery at the 15th Quadrennial Meeting of the World Society for Stereotactic and Functional Neurosurgery (WSSFN) that took place in Toronto, Canada, from May 24th to 27th 2009. These included the neuromate® surgical robot, and image-guided stereotactic technologies, some of which are still in development.